Antimicrobial nanocoatings reduce bacterial contamination in contact lenses, suggesting a safer option for wearers.
Antimicrobial nanocoatings show strong potential, achieving >3-log₁₀ bacterial reductions and reducing corneal infiltrative events in trials. Future work should focus on hybrid, stimuli-responsive coatings that activate under infection-specific conditions, ensure long-term safety, and meet manufacturing and regulatory requirements.
No takes yet. Share an insight, caveat, or question.
Sara et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: